Open Access

Burden of migraine in a Kuwaiti population: a door-to-door survey

  • Jasem Yousef Al-Hashel1, 2Email author,
  • Samar Farouk Ahmed1, 3 and
  • Raed Alroughani4
The Journal of Headache and PainOfficial Journal of the "European Headache Federation" and of "Lifting The Burden - The Global Campaign against Headache"201718:105

https://doi.org/10.1186/s10194-017-0814-2

Received: 16 July 2017

Accepted: 30 September 2017

Published: 13 October 2017

Abstract

Background

Migraine prevalence and disability imprints on Kuwaiti population are underreported. We aimed to measure the prevalence of migraine and to assess its burden in Kuwait.

Methods

A cross-sectional community-based study was conducted which included biologically unrelated Kuwaiti adult population aged 18–65 years. They were randomly recruited from all six governments of Kuwait using stratified multistage cluster sampling. Trained interviewers visited the samples in door-to-door approach. The Headache-Attributed Restriction, Disability, and Social Handicap and Impaired Participation (HARDSHIP) questionnaire was used to collect the data. Demographic enquires were followed by diagnostic and disability questions.

Results

A total of 15,523 subjects were identified; of whom 3588 (23%) were diagnosed as episodic migraine and 845 (5.4%) as chronic headache. Prevalence of episodic migraine was 31.71% in female versus 14.88% in males (P < 0.01) with a mean age of 34.56 ± 10.17 years. Most of migraine cohort (64.4%) sought medical advice with respect to their migraine headaches and the majority (62.4%) were seen by general practitioners (GPs) while 17.2% were assessed by neurologists and 3.7% was seen by other specialties. Tension type headache and sinus-related headaches were diagnosed in 8.9% and 2.1% of migraine subjects respectively. The majority (94.6%) of migraine subjects used symptomatic drugs for headache attacks, whereas 39.9% were taking preventive medication. In the preceding 3 months to the survey, subjects with episodic migraine had lost a mean of 1.97 days from their paid work or school attendance compared to 6.62 days in chronic headache sufferers (P < 0.001). Additionally, subjects with episodic migraine lost a mean of 1.40 days from household work compared to 5.35 days in subjects with chronic headache (P < 0.001). Participants with episodic migraine and chronic headache missed a mean of 2.81 and 3.85 days on social occasions, in the preceding 3 months (P < 0.001).

Conclusions

Migraine in Kuwait is highly prevalent and it has a significant impact on activity of daily living, schooling/ employment and social occasions of patients. Accurate diagnosis, effective abortive and preventive treatments of migraine are paramount to improve quality of life and as well as cost saving.

Keywords

EpidemiologyPrevalenceMigraineBurdenKuwait

Background

Migraine prevalence is highest during the productive years of individuals between the ages of 25 and 55 [1]. Migraine may cause significant impact on activity of daily living including physical and emotional functions [2]. Global Burden of Disease Survey (GBD) 2010 [3] estimated that the global prevalence of migraine is approximately 15% and migraine was ranked as third most common diseases in the world behind dental caries and Tension type headache (TTH). In 2013, migraine was recognized as the sixth-highest cause of disability in the world [4]. Migraine is a lifelong illness causing remarkable disability during the headache attacks, along with substantial financial burden to the patient as well as to the society. It also affects family and social relationships and impoverishes quality of life [5, 6]. In approximately 2% of the population, a chronic form of migraine became more evident resulting in a significant impact on daily activities [7]. Migraine prevalence in Saudi Arabia, Qatar and Oman, is within the estimated worldwide prevalence range of 0.7–21.9% [8]. The lifetime migraine prevalence in the three Gulf countries was lower than in European studies, which report a range of 12–28% [9]. Migraine disability imprints on Kuwaiti population were underreported since the GBD2010 [2] and GBD2013 [3] estimation for migraine were derived from limited data extracted from hospital-based studies. Hence, our study aimed to assess the prevalence of migraine and its burden in Kuwait through a comprehensive approach utilizing a door-to-door survey. In a prior publication, we reported on prevalence of primary headache disorders. In the present study, we further report on the prevalence of episodic migraine stratified by age and gender, characters of migraine in addition to its burden, which was not shown in our previous published paper [10].

Methods

The full methodology was described elsewhere [10]. The fieldwork was carried out between January 2016 and April 2016. A population-based multistage random cluster sampling was conducted. Kuwaiti adults aged 18–65 years who were living in Kuwait for the last 6-month were identified. Adults who have deafness or major mental illness were excluded because of the communication difficulties with the interviewers. One adult member of each household was randomly selected after obtaining an informed consent. The interviewers consisted of 4 nurses and 10 medical students who were native Arabic speakers. The survey used several questionnaires such as Lifting The Burden (LTB) [11], Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire [12, 13] which were all translated into Arabic. Subjects were asked if all their headaches were of one or more types and, if more than one headache were identified, subsequent questions were focused on the one that was the most bothersome. The authors J.Y.A.-H. and S.F.A. established the diagnosis using an algorithm that was developed by LTB questionnaire [14] and based on ICD-II criteria [15]. Written informed consent was obtained from all the participants and they were free to decline participation at any time during the interviews.

Data analysis

Data of completed questionnaires were entered into SPSS version 20.0. Collected data was analyzed to assess 1-year prevalence for migraine headache as percentages with 95% confidence intervals (CIs). Prevalence of migraine was stratified by gender and age. Estimates both genders according to age categories (18–30, 31–40, 41–50 and 51–65) were calculated. Categorical variables were described in terms of frequency and proportions (%, with 95% CIs where appropriate), continuous variables in terms of means and standard deviations (SDs). We used chi-square to compare distributions between categorical variables and t-test to compare between numerical variables. We used Pearson’ s coefficient to test for correlation between continuous variables. We considered a P value of <0.05 as statistically significant.

Results

The interviewers collected 16,332 questionnaires, of which 15,523 were complete and subsequently used for analysis. The participation rate was 53.26%. The study sample presented 1.23% of the general population. A flowchart of the participants was published in our earlier paper [10]. Males represent 51.1% (n = 7925) of the analyzed sample. The mean age of the overall sample was 37.51 ± 11.82 years.

Among the total respondents, 23.1% (n = 3588) were diagnosed with episodic migraine while 5.4% (n = 845) were diagnosed as chronic headache. The 1-year prevalence of episodic migraine was significantly higher in female (31.71%) versus. Males (14.88%); p < 0.01. The majority of the migraine population was female (67%). The mean age of migraine subjects was significantly lower than subjects without migraine (34.56 ± 10.17 vs. 41.67 ± 12,94; p < 0.01). On the other hand, females with migraine were significantly younger than males with migraine (34.17 ± 10.70 vs. 35.43 ± 8.92; p < 0.01).

Table 1 shows the 1-year prevalence of migraine headache stratified by age and gender. Migraine prevalence is based on the reported most bothersome headache. Age specific prevalence of episodic migraine was higher in age group 18–30 (27%) compared to other age groups. Beyond 50 years of age, the prevalence fell in both genders (males: 0.5%; females 14%).
Table 1

One-year prevalence of Episodic Migraine Headache stratified by age and gender

Episodic Migraine

Total

Male

Female

P

Age (years)

Participant populations

Migraine cases

Prevalence

% (CIs 95%)

Participant populations

Migraine cases

Prevalence

% (CIs 95%)

Participant populations

Migraine cases

Prevalence

% (CIs 95%)

18–30

5056

1382

27.33

(17.48–28.89)

2762

415

15.05

(6.06–16.44)

2294

967

42.1

(30.8–58.4)

0.001*

31–40

4997

1292

25.86

(17.36–72.19)

2433

431

18.1

(6.4–19.70)

2564

861

32.93

(18.3–64.3)

0.02*

41–50

3198

752

23.54

(22.10–25.05)

1511

327

21.66

(19.60–23.82)

1687

425

25.18

(23.12–27.32)

0.43

51–65

2272

162

7.13

(6.11–8.27)

1219

6

0.5

(0.13–1.3)

1053

156

14.81

(12.11–17.84)

0.001*

Total

15,523

3588

23.11

(19.43–32.87)

7925

1179

14.88

(9.54–57.9)

7598

2409

31.70

(32.87–45.24)

0.01*

CI confidence interval

*Significant P Value

The characteristics of episodic migraine headache were summarized in Table 2. Mean days of headache in the last month in our study were 6.67. The majority (60%) had migraine headaches of moderate intensity. Most of migraine cohort (64.4%) sought advice of health services. Most of the migraine headache patients (62.4%) were seen by general practitioners (GPs) while neurologist, and other specialties saw 17.2% and 3.7% of patients respectively (P < 0.001). Only 4.6% of migraine cohort received a migraine diagnosis from a medical professional while, 8.9% was diagnosed as tension type headache and 2.1% were diagnosed as sinus headache. The majority (94.6%) of migraine subjects used symptomatic drugs for their headache attacks during the past month, whereas 39.9% were taking preventive medication at the time of the survey.
Table 2

Character of episodic migraine headache among Kuwaiti populations (N = 3588)

Variables

M ± SD/No (%)

Mean Age

34.56 ± 10.17

Marital state

 • Single

641 (17.9)

 • Married

2738 (67.3)

 • Divorced

100 (2.8)

 • Widow

109 (3)

Education

 • University

2269 (63.2)

 • High School

1164 (32.4)

 • Primary School

17 (0.4)

Employment

 • Full time

2513(70)

 • Part time

538 (15)

 • Student

170 (4.7)

 • Housewife

239 (6.7)

 • Not working

128 (3.6)

Frequency of attacks/month

6.67 ± 2.33

Duration of attacks in hours

6.08 ± 334

Severity of headache

 • Not bad

35 (1.4)

 • Quite bad

2170 (60.4)

 • Very bad

1369 (38.2)

Treatments taken

 • Symptomatic treatment

3395 (94.6)

 • Prophylactic treatment

1433 (39.9)

Use Health service

2309 (64.4)

Consultations

 • General practitioner

2253 (62.8)

 • Neurologist

616 (17.2)

 • Persons prescribing Traditional Medicine

586 (16.3)

 • Other specialties

81 (2.3)

M Mean, SD standard deviation

There were significant positive correlations between both frequency of migraine attacks and lost days as shown in Table 3. The more frequent the attacks were, the more lost days observed in the preceding 3 months of the survey. However, the severity of attacks had only a negative impact on the social and family activities.
Table 3

Impact of migraine attacks assessed by HALT questionnaire in preceding 3 months

Variables

Lost workdays

Lost housework days

Lost social and family days

Frequency of attacks/month

R = 0.082

P = 0.001*

R = 0.125

P = 0.001*

R = 0.141

P = 0.001*

Severity of migraine attacks

R = 0.029

P = 0.098

R = 0.022

P = 0.181

R = 0.047

P = 0.005*

HALT índex headache-attributed lost work, housework and social days

*Significant P Value

The cumulative number of lost days according to the HALT index was outlined in Table 4. Subjects with chronic headaches had a significantly higher burden. Subjects with episodic migraine had lost a mean of 1.97 days from their paid work or school attendance, versus 6.62 lost days in patients with chronic headache (p < 0.001). Similarly, subjects with episodic migraine lost a mean of 1.40 days from their household work versus 5.35 lost days in subjects with chronic headache (p < 0.001) in the preceding 3 months of the survey. Regarding social and family activities, subjects with episodic migraine and chronic headache missed mean of 2.81 and 3.85 days in the preceding 3 months of the survey (P < 0.001).
Table 4

Impact of episodic migraine versus chronic headache assessed by HALT questionnaire in preceding 3 months

Variables

Episodic Migraine

M ± SD

Chronic Headache

M ± SD

P value

Work days

1.87 ± 1.71

6.62 ± 2.41

0.001*

Housework days

1.44 ± 1.83

5.35 ± 2.36

0.001*

Social and family days

2.81 ± 1.75

3.85 ± 2.95

0.001*

HALT índex headache-attributed lost work, housework and social days, M Mean, SD standard deviation

*Significant P Value

Discussion

The study captured data from all six governmental sectors of Kuwait. The 1-year prevalence of migraine in our study was 23%, which was higher than previous studies conducted in Arab Gulf countries (Qatar 7.9% [16] and in Oman 10.1% [17]). Our result was similar to the prevalence for other international figures of 22% in Georgia [18], 25.2% in Pakistan, [19], 20.8% in Russia [20] 25.6 in India [21], 22.9% in Zambia [22], and 29% in Turkey [23]. On the other hand, our result was higher than that of the global estimate (14.7%) [2] other countries such as Colombia (13.7%) [24], Germany (18%) [25] and China study (9.3%) [26]. In Italy, migraine 1-year prevalence was 42.9%; which is much higher than our result (5) and also the 1-year prevalence of migraine in Eurolight project 35.3% [27] The discrepancies in the prevalence figures could be attributed to methodological differences, and to genetic, environmental or cultural factors. Our estimation of migraine prevalence in the Kuwaiti population is matching to our previous estimation of migraine among medical students (27.9%) [28]. Our study reported a female preponderance of 67% that could be hormonally determined which is consistent with previous studies [29].

More than 38% of migraine subjects were younger than 30 years of age and approximately 68% were in the age group between 18 to 50 years of age similar to previous published studies [19, 20, 23]. The highest age specific prevalence of episodic migraine in our cohort is 27.3% in the age group 18–30 years and the lowest prevalence is in the age group 51–65 years. Prevalence of migraine in females is high in the 18–30 age group and middle age group (31–40 years) but sharply declined in the postmenopausal age group (51–65 years), which is similar to previous reports [20, 24]. These trends can be attributed to the well-documented influence on migraine of estrogen levels [29]. However migraine prevalence declined also in our male cohorts older than 50 years.

Most of migraine cohort sought medical advice for their headaches. Although the majority was seen by their GPs, only 4.6% received accurate diagnosis of migraine. A study conducted in the UK [30] indicated that 70% of migraine headache patients were not given a diagnostic label, by GPs. It was suggested that GPs’ difficulty in diagnosing migraine headache presentations results in increase in the impact of migraine headaches on activity of daily living. [31]. Interestingly, in our study, migraine cohort showed that seeking traditional Arab treatment, like; Hijama is nearly equal to seeking neurologist. A significant number of our population continues to believe in this type of treatment, which is performed by non-medical personnel. The community awareness with migraine needs to be improved and the education of the primary care providers is an important step in this aspect to limit the numbers of under-diagnosed or misdiagnosed patients. This high percentage of patients who sought medical advice reflects the impact of migraine on health resources. Previous studies reported that headache was one of the highest indications seen by general practitioners and neurologists [32, 33]. A survey of neurologists indicated that up to a third of all their referral were related to headaches [34]. We reported that 94.6% of our cohort had used acute medication, which was nearly similar to an Austrian study, which reported that 94.4% had used acute abortive medications. Similarly, the proportion of patients who used prophylactic medication in our study (39.9%) was comparable to the Austrian study (34%) [35].

Despite the significant burden of migraine in different countries, the impact of migraine on daily activities was poorly described in Kuwait. We reported that subjects with episodic migraine lost an average 1.8 days from their paid work in the preceding 3 months to the survey, which was nearly similar to an Italian study of 2.3 lost days [5] and Eurolight project that reported mean lost workdays about 1 day/ month [27]. The frequency of migraine attacks in our cohort was significantly correlated with missing working, school and social days, and household activities during their migraine attack. Our results were in line with previous findings of a direct correlation between attack frequency and migraine-related disability for people with migraine [36].

Social activity and work capacity were reduced in almost all people with migraine [37]. Our results reported chronic headache in 5.4% of the total cohort. We demonstrated that the rate of disability days per month (using HALTquestionnaire) was significantly higher in chronic headache participants compared to episodic migraine participants. This is consistent with previous studies [35, 36, 3840]. Thus, chronic headache participants were less able to perform work and leisure activities than those with episodic migraine participants. Chronic headache might affect family and social life along with employment [37, 38].

Since migraine is most troublesome in the productive years, its public health importance lies in its causal association with these personal and societal burdens of pain, disability, damaged quality of life and financial cost [40]. Many governmental and nongovernmental stakeholders do not recognize that the direct costs of migraine management is smaller when compared with the large indirect-cost savings that might be made from reducing lost working days, school days, social activities [5, 26, 41, 42].

One major limitation that needs to be outlined is the sampling methodology. Although we propose a probability sample method (cluster sampling), it is not adjusted for gender and age according to the participation of the Kuwaiti population; hence it may not entirely reflect the distribution of the whole population. To minimize this potential source of bias, we used a large sample.

Another limitation was the recall bias, which is usual in most of the studies using questionnaire. On the other hand, this study is the first and largest population-based survey in Kuwait to estimate the prevalence of migraine headache, and the first to measure migraine-attributed burden.

Conclusions

Migraine is prevalent in Kuwait and has a significant socioeconomic burden especially in its chronic form. Improving the public awareness of migraine through health education of primary care providers and public media may reduce the misdiagnosis and subsequently result in better quality of life and reduce the economic burden.

Abbreviations

CIs: 

Confidence intervals

GBD: 

Global Burden of Disease Survey

GPs: 

General practitioners

HALT: 

Headache-Attributed Lost Time Index questionnaire

HARDSHIP: 

Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation questionnaire

LTB: 

Lifting The Burden

SDs: 

Standard deviations

TTH: 

Tension type headache

Declarations

Acknowledgements

We would like to thank the study participants and the nurses for actively participating.

Funding

This study was partly funded by scientific grant from Kuwait University, Research Sector.

Authors’ contributions

JA was the project leader and contributed to project design and development of the methodology, SA: contributed to project design and development of the methodology, data acquisition and statistical analysis and drafted the manuscript. RA revised the manuscript critically. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The faculty of Medicine, Kuwait University approved the study. The project tittle is MM02/15.

Competing interest

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)
Neurology Department, Ibn Sina Hospital
(2)
Faculty of Medicine, Kuwait University
(3)
Neuropsychiatry department, Faculty of Medicine, Al-Minia University
(4)
Division of Neurology, Department of Medicine, Amiri Hospital

References

  1. Burch RC, Loder S, Loder E, Smitherman TA (2015) The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache 55:21–34View ArticlePubMedGoogle Scholar
  2. Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO’s classification of functioning, disability and health (ICF). Journal of headache and Pain 6:429–440View ArticlePubMedPubMed CentralGoogle Scholar
  3. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380:2163–2196View ArticlePubMedGoogle Scholar
  4. Global Burden of Disease Study 2013 Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013 (2015). Lancet 386(9995):743–800Google Scholar
  5. Allena M, Steiner TJ, Sances G, Carugno B, Balsamo F, Nappi G, Andrée C, Tassorelli C (2015) Impact of headache disorders in Italy and the public-health and policy implications: a population-based study within the Eurolight project. J Headache Pain 16:100View ArticlePubMedPubMed CentralGoogle Scholar
  6. WHO, Lifting the burden (2011). Atlas of headache disorders and resources in the world 2011. http://www.who.int/mental_health/management/atlas_ headache_disorders/en/_headache_disorders/en/
  7. Manack AN, Buse DC, Lipton RB (2011) Chronic migraine: epidemiology and disease burden. Curr Pain Headache Rep 15:70–78View ArticlePubMedGoogle Scholar
  8. Scher AI, Stewart WF, Lipton RB (1999) Migraine and headache: a meta-analytic approach. In: Crombie IK (ed) Epidemiology of pain; IASP press, WA, pp 159–170Google Scholar
  9. Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J) (2006). Epidemiology of headache in Europe. Eur J Neurol; 13:333–345View ArticlePubMedGoogle Scholar
  10. Al-Hashel J, Ahmed SF, Alroughani R (2017) Prevalence of primary headache disorders in Kuwait. Neuroepidemiology 48:138–146View ArticlePubMedGoogle Scholar
  11. Steiner TJ, Birbeck GL, Jensen R, Katsarava Z, Martelletti P, Stovner LJ (2011) The global campaign, World Health Organization and lifting the burden: collaboration in action. Journal of headache and Pain 12:273–274View ArticlePubMedPubMed CentralGoogle Scholar
  12. Steiner TJ, Lifting the burden (2005) The global campaign to reduce the burden of headache worldwide. J Headache Pain 6:373–377View ArticlePubMedPubMed CentralGoogle Scholar
  13. Steiner TJ, Gururaj G, Andrée C, Katsarava Z, Ayzenberg I, SY Y, Al Jumah M, Tekle-Haimanot R, Birbeck GL, Herekar A, Linde M, Mbewe E, Manandhar K, Risal A, Jensen R, Queiroz LP, Scher AI, Wang SJ, Stovner LJ (2014) Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain. 15:30View ArticleGoogle Scholar
  14. Steiner TJ (2004) Lifting the burden: the global campaign against headache. Lancet Neurol 3:204–205View ArticlePubMedGoogle Scholar
  15. Headache Classification Subcommittee of the International Headache Society: The international classification of headache disorders, ed 2. Cephalalgia 2004; 24(suppl 1):9–160Google Scholar
  16. Bener A (2006) Frequency of headache and migraine in Qatar. Neuroepidemiology 27:61–66View ArticlePubMedGoogle Scholar
  17. Deleu D, Khan MA, Al Shehab TA (2002) Prevalence and clinical characteristics of headache in a rural community in Oman. Headache 42:963–973View ArticlePubMedGoogle Scholar
  18. Katsarava Z, Kukava M, Mirvelashvili E, Tavadze A, Dzagnidze A, Djibuti M, Steiner TJ (2007) A pilot methodological validation study for a population based survey of the prevalence of migraine, tension -type headache and chronic daily headache in the country of Georgia. J Headache Pain 8:77–82View ArticlePubMedPubMed CentralGoogle Scholar
  19. Herekar AA, Ahmad A, Uqaili UL, Ahmed B, Effendi J, Alvi SZ, Shahab MA, Javed U, Herekar AD, Khanani R, Steiner TJ (2017) Primary headache disorders in the adult general population of Pakistan – a cross sectional nationwide prevalence survey. J Headache Pain 18:28View ArticlePubMedPubMed CentralGoogle Scholar
  20. Ayzenberg I, Katsarava Z, Sborowski A, Chernysh M, Osipova V, Tabeeva G, Yakhno N, Steiner TJ (2012) The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia 32:373–381View ArticlePubMedGoogle Scholar
  21. Kulkarni GB, Rao GN, Gururaj G, Stovner LJ, Steiner TJ (2015) Headache disorders and public ill-health in India: prevalence estimates in Karnataka state. J Headache Pain 16:67View ArticlePubMedPubMed CentralGoogle Scholar
  22. Mbewe E, Zairemthiama P, Yeh HH, Paul R, Birbeck GL, Steiner TJ (2015) The epidemiology of primary headache disorders in Zambia: a population-based door-to-door survey. J Headache Pain 16(1):515PubMedGoogle Scholar
  23. Ertas M, Baykan B, Orhan EK, Zarifoglu M, Karli N, Saip S, Onal A, Siva A (2012) One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain 13:147–157View ArticlePubMedPubMed CentralGoogle Scholar
  24. Rueda-S.nchez M, d az-Martnez LA (2008) Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia 28(3):216–225View ArticleGoogle Scholar
  25. Yoon MS, Katsarava Z, Obermann M, Fritsche G, Oezyurt M, Kaesewinkel K, Katsarova A, Santowski I, Diener H, Moebus S (2012) Prevalence of primary headaches in Germany: results of the German headache consortium study. J Headache Pain 13:215–223View ArticlePubMedPubMed CentralGoogle Scholar
  26. Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, Fang Y, Cao X, He M, Steiner T (2012) The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache 52:582–591View ArticlePubMedGoogle Scholar
  27. Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la torre E, Tassorelli C, Barré J, Andrée C (2014) The impact of headache in Europe: principal results of the Eurolight project. The Journal of Headache and Pain 15:31View ArticlePubMedPubMed CentralGoogle Scholar
  28. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PG (2014) Migraine among medical students in Kuwait University. The Journal of Headache and Pain 15:26View ArticlePubMedPubMed CentralGoogle Scholar
  29. Brandes JL (2006) The influence of estrogen on migraine: a systematic review. JAMA 295:1824–1830View ArticlePubMedGoogle Scholar
  30. Kernick D, Stapley S, Hamilton W (2008) GPs’ classification of headache: is primary headache under diagnosed? Br J Gen Pract 58:102–104View ArticlePubMedPubMed CentralGoogle Scholar
  31. World Health Organization (2004) Headache disorders. In: Fact sheet N°277 Accessed on 28 June 2010Google Scholar
  32. Schwartz BS, Stewart WF, Lipton RB (1997) Lost workdays and decreased work effectiveness associated with headache in the workplace. J Occup Environ Med 39:320–327View ArticlePubMedGoogle Scholar
  33. Hopkins A, Menken M, De Friese GA (1989) A record of patient encounters in neurological practice in the United Kingdom. Journal of Neurology Neurosurgery and Psychiatry 52:436–438View ArticleGoogle Scholar
  34. Laughey WF, Holmes WF, Mac Gregor AE, Sawyer JPC (1999) Headache consultation and referral patterns in one UK general practice. Cephalalgia 19:328–329View ArticleGoogle Scholar
  35. Zebenholzer K, Andree C, Lechner A, Broessner G, Lamp C, Luthringshausen G, Wuschitz A, Obmann SM, Berek K, Wöber C (2015) Prevalence, management and burden of episodic and chronic headaches—a crosssectional multicentre study in eight Austrian headache centers. The Journal of Headache and Pain 16:46View ArticlePubMed CentralGoogle Scholar
  36. Bigal ME, Rapoport AM, Lipton RB et al (2003) Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine. Headache 43:336–342View ArticlePubMedGoogle Scholar
  37. Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TL (2003) The family impact of migraine: population-based studies in the US and UK. Cephalalgia 23:429–440View ArticlePubMedGoogle Scholar
  38. Buse DC, Manack AN, Serrano D, Varon SF, Turkel LRB (2012) Headache impact of chronic and episodic migraine: predictors of impact from the American migraine prevalence and prevention (AMPP) study. Headache 52(1):3–17View ArticlePubMedGoogle Scholar
  39. Bigal ME, Serrano D, Reed M et al (2008) Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 71:559–566View ArticlePubMedGoogle Scholar
  40. Adams AM, Serrano D, Buse DC, Reed ML, Marske V, Fanning KM, Lipton RB (2015) The impact of chronic migraine: the chronic migraine epidemiology and outcomes (CaMEO) study methods and baseline results. Cephalalgia; Vol 35(7):563–578View ArticleGoogle Scholar
  41. Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J (2011) Association between migraine, lifestyle and socioeconomic factors: a population-based cross-sectional study. Journal of headache and Pain 12:157–172View ArticlePubMedPubMed CentralGoogle Scholar
  42. Stovner LJ, Hagen K (2006) Prevalence, burden, and cost of headache disorders. Curr Opin Neurol 19:281–285View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017